Clinical Trial Update: 7-week Study With CT-155 in People With Schizophrenia [NA]

View source ↗

Summary

A 7-week clinical trial evaluating CT-155 in people with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• CT-155

Snippet

Sponsor: Click Therapeutics, Inc. | Conditions: Schizophrenia | NA | Status: COMPLETED